Millipore Sigma Vibrant Logo

509612 InSolution™ TAPI-2 - CAS 187034-31-7 - Calbiochem

A 10 mM (1 mg/241 µL) sterile-filtered solution of TAPI-2 in H₂O.

MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.
View Products on Sigmaaldrich.com
509612
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
187034-31-7C₁₉H₃₇N₅O₅

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
5096120001
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Bottiglia di vetro 1 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      Catalogue Number509612
      Brand Family Calbiochem®
      References
      ReferencesBennett, T.A., et al. 2000. J. Immunol. 164, 4120.
      Fiorucci, S., et al. 1998. Aliment. Pharmacol. Ther. 12, 1139.
      Hooper, N.M., et al. 1997. Biochem. J. 321, 265.
      Parvathy, S., et al. 1997. Biochem. J. 327, 37.
      Arribas, J., et al. 1996. J. Biol. Chem. 271, 11376.
      Product Information
      CAS number187034-31-7
      FormLiquid
      FormulationA 10 mM (1 mg/241 µL) sterile-filtered solution of TAPI-2 (Cat. No. 579052) in H₂O.
      Hill FormulaC₁₉H₃₇N₅O₅
      Chemical formulaC₁₉H₃₇N₅O₅
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Aliquots are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      5096120001 04055977240986

      Documentation

      InSolution™ TAPI-2 - CAS 187034-31-7 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Riferimenti bibliografici

      Panoramica delle referenze
      Bennett, T.A., et al. 2000. J. Immunol. 164, 4120.
      Fiorucci, S., et al. 1998. Aliment. Pharmacol. Ther. 12, 1139.
      Hooper, N.M., et al. 1997. Biochem. J. 321, 265.
      Parvathy, S., et al. 1997. Biochem. J. 327, 37.
      Arribas, J., et al. 1996. J. Biol. Chem. 271, 11376.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-April-2014 JSW
      DescriptionA hydroxamate-based inhibitor of matrix metalloproteinases and TACE (TNF-α convertase; ADAM17). Inhibits the activation-dependent shedding of L-selectin from neutrophils, eosinophils, and lymphocytes as well as phenylarsine oxide (PAO)-induced shedding in neutrophils. Also blocks the shedding of several cell surface proteins such as pro-TGF-α, IL-6 receptor α-subunit, and β-amyloid precursor protein. Reported to inhibit TNF-α release and impart protection against aspirin-induced gastric mucosal injury. Acts as a weak inhibitor of angiotensin converting enzyme (IC50 = 18 µM).
      FormLiquid
      FormulationA 10 mM (1 mg/241 µL) sterile-filtered solution of TAPI-2 (Cat. No. 579052) in H₂O.
      Intert gas (Yes/No) Packaged under inert gas
      CAS number187034-31-7
      Chemical formulaC₁₉H₃₇N₅O₅
      Purity≥97% by HPLC
      Storage Protect from light
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C). Aliquots are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBennett, T.A., et al. 2000. J. Immunol. 164, 4120.
      Fiorucci, S., et al. 1998. Aliment. Pharmacol. Ther. 12, 1139.
      Hooper, N.M., et al. 1997. Biochem. J. 321, 265.
      Parvathy, S., et al. 1997. Biochem. J. 327, 37.
      Arribas, J., et al. 1996. J. Biol. Chem. 271, 11376.